We have cloned the gene for the chicken erythroid transcription factor GATA-1 (formerly Eryfl, NFEl, or GF-1). The gene is composed of six exons, two of which encode the two finger domains of the protein. Transcription of GATA-1 in chicken embryonic erythroid cells initiates from multiple sites clustered -200 base pairs upstream from the start of protein-coding sequence. A number of sequence motifs for known DNA-binding proteins are found to be protected in DNase I-footprinting experiments by either erythroid or brain nuclear extracts or by both. Notably, a cluster of three GATA-1 sites is protected by the erythroid extract, as well as by purified GATA-1. We find that the upstream region of the gene functions as a powerful promoter when transfected into embryonic erythroid cells. In primary chicken embryo fibroblasts the promoter exhibits lower activity, which is increased when the cells are cotransfected with a second plasmid expressing the GATA-1 cDNA. The results suggest that GATA-1 protein plays an autoregulatory role in its own expression. The cDNAs for chicken GATA-1 (8), as well as the mouse and human homologs (9-11), have been cloned. All possess a highly conserved DNA-binding domain containing two copies (with >60% amino acid identity) of a "finger" motif, of the form Cys-Xaa-Asn-Cys-Xaa4-Thr-Xaa-Leu-Trp-ArgArg-Xaa3-Gly-Xaa-Cys-Asn-Ala-Cys.
GATA-1 [previously called Eryfl, NF-E1, or GF-1 (1-3)] § is a tissue-specific DNA-binding protein found at all stages of erythroid development in vertebrates. Strong binding sites for GATA-1, with a conserved motif WGATAR, are widely distributed throughout the promoters and enhancers of the globins and other erythroid-specific genes. For example, there is at least one GATA-1-binding site near every member of the 83-and a-globin gene families of chicken (1) . Transfection studies in erythroid cells have demonstrated the functional importance of GATA-1-binding sites (1, 3, 4) , whereas transactivation experiments with GATA-1 expression vectors in nonerythroid cells have shown directly that GATA-1 has a strong positive effect on transcription (5) (6) (7) .
The cDNAs for chicken GATA-1 (8) , as well as the mouse and human homologs (9) (10) (11) , have been cloned. All possess a highly conserved DNA-binding domain containing two copies (with >60% amino acid identity) of a "finger" motif, of the form Cys-Xaa-Asn-Cys-Xaa4-Thr-Xaa-Leu-Trp-ArgArg-Xaa3-Gly-Xaa-Cys-Asn-Ala-Cys.
We report here the isolation of a genomic clone for chicken GATA-1. MATERIALS AND METHODS Cloning. A chicken genomic library was constructed in EMBL-3 (12) by using erythrocyte DNA that was partially digested with Sau3a. The library was screened with a GATA-1 cDNA fragment [the insert of clone 11-4, (8) ]. The insert of one clone (9.2e.232.2) spanning the entire cDNA was mapped by hybridizing labeled terminal fragments to dried gels containing partial restriction digests (13) . Fragments containing coding sequences were identified by hybridizing similar gels, containing complete restriction digests of the clone 9.2e.232.2 insert, with a variety of synthetic oligonucleotide probes derived from the published cDNA sequence. Appropriate restriction fragments were subcloned into Bluescript (Stratagene) and sequenced as doublestranded plasmids by using Sequenase (United States Biochemical). The subclone pNco650 contains a 656-bp genomic Nco I fragment extending upstream from the GATA-1 translation initiation site. The insert was ligated (blunt) into the EcoRV site of Bluescript KS(+) (Fig. 2) . S1 Mapping and Primer Extension. RNA was isolated as described (8) . For S1 nuclease protection assays, 40 ,g of total RNA was coprecipitated with 10 ng (3 pmol) of a 5'-end-labeled 98-mer probe (Fig. 3A) . Samples were incubated [40 ,ul of 80%o (vol/vol) formamide/0.4 M NaCl/10 mM Pipes buffer, pH 6.5] overnight at 48°C, before digestion with S1 nuclease for 30 min at 37°C. Primer-extension assays were done by using 20-or 31-mer probes with the same 5' end as the 98-mer probe used in the S1 mapping studies, allowing comparison of extension products and S1-protected fragments against the same sequencing ladder on the same gel. Twenty micrograms of total RNA was coprecipitated with either 5'-labeled primer and resuspended in 30 ,u1 ofthe hybridization buffer described above. The samples were hybridized overnight at room temperature (20-mer) or 30°C (31-mer). Extension reactions (100 ,ul) consisted of 50 mM Tris, pH 7.6/60 mM KCI/10 mM MgCl2/1 mM dithiothreitol/1 mM each dNTP/actinomycin D at 50 ,ug/ml/Promega RNasin at 1 unitlml/400 units of Moloney murine leukemia virus reverse transcriptase (BRL). Reactions were incubated at 37°C for 2 hr.
DNase I Protection. Preparation of nuclear extracts, generation of DNA probes, and digestions by DNase I were done as described (14) . Partial purification of GATA-1 by DNAcellulose chromatography and purification by sequencespecific DNA-affinity chromatography were as described (8 5' or 3' strand. The plasmids were then digested with the complementary enzyme, and the fragments, labeled on one strand, were gel-purified.
Transfection. Test plasmids were constructed by inserting GATA-1 promoter elements upstream of the chloramphenicol acetyltransferase (CAT) gene in the vector pCAT-Basic (Promega). pGATP1 carries a HindIII-Dra II restriction fragment excised from pNco650 that contains GATA-1 sequence from the 5' end of the insert to -10 bp upstream of the ATG initiation codon in the GATA-1 sequence and includes the first intron (Fig. 2) ; this fragment is inserted into the Sal I site of pCAT-Basic. pGATP2 carries the smaller HindIII-Pst I fragment from this region (to -172) inserted into the HindIII-Pst I sites ofpCAT-Basic. The expression plasmid pRSV20-2, which carries GATA-1 cDNA coupled to the Rous sarcoma virus promoter/enhancer, control pRSV20-1, and transfection assays have been described (5) . CAT activity was normalized to ,B-galactosidase activity derived from a cotransfected internal control lacZ expression plasmid (5) . RESULTS Multiple GATA-1 Start Sites Are Clustered in a Small Region. The nucleotide sequence of an Nco I fragment, extending 656 bp in the 5' direction from the ATG translation start codon in the second exon, is presented in Fig. 2 . This sequence was used to design a probe for S1 nuclease mapping of mRNA start sites. In these experiments a complementary 98-mer probe was used that extends 80 nucleotides 5' of the ATG translation initiation codon (see Fig. 3A ).
GATA-1 Fingers
Multiple fragments are seen to be protected from digestion by S1 nuclease after hybridization of the 98-mer to total RNA from day-12 embryonic erythroid cells (15) (Fig. 3B, lanes 1  and 2) . The majority of the protected fragments are concentrated in a short region (labeled I in Fig. 3B ) 206-222 nucleotides upstream of the ATG coding start. Within this region, four major start sites are indicated at -209, -210, -213, and -214; an additional cluster of weak sites is seen at -184 to -187 (labeled III). There are a few other weak sites (labeled II) near the 3' end of the probe, which are not seen in the primer-extension experiments described below. A similar pattern of protected fragments is observed with total RNA from the (uninduced) chicken erythroblast cell line HD3 (15) (Fig. 3B, lanes 3 and 4) . No protected fragments are seen with RNA from either day-10 chicken brain (lanes 5 and 6) or yeast (lanes 7 and 8). To confirm these results, we mapped the 5' ends of GATA-1 transcripts by primer-extension analysis with two primers that hybridize near the 5' end of the coding sequence (see Fig. 3A ). The majority of the extension products map to the same region (I) as the major S1 nucleaseprotected fragments (lane 13). Although many of these ex- Fig. 3 ) are marked by large and small vertical arrows. The region containing overlapping consensus binding sites forGATA-l is boxed; a consensus binding site for c-myb is also indicated. Sequences protected in the footprint experiments (Fig. 4) Fig. 4 and only approximately located. (Lower) Tissue specificity (E, erythroid; B, brain) and possible factors responsible for the footprints marked above. Factor abbreviations are as follows: BG, BGP1; CAC, CACCC-binding factor; GA, GATA-1; and HR, hormone receptor. Site numbers correspond to those in Upper. Fragment numbers show labeling scheme used in footprints of Fig. 4 (e.g., fragment 1 is labeled at 5' end of lower strand and maps sites in direction of arrow). Fig. 2 , by using nuclear extracts made from either erythroid or brain cells of day-9 chicken embryos. The GATA-1 gene has been shown to be highly expressed in the erythroid, but not in brain, cells (8) . We find ( Fig. 4 ; summarized in Fig. 2 ) at least 13 protected regions, some generated by extracts from both sources and others either erythroid-or brain-specific. Notable among these is the cluster of three GATA-1 sites, strongly protected by erythroid (but not brain) nuclear extracts. The same sites are also protected by purified GATA-1 protein (Fig. 4D) . A fourth, weaker, GATA-1 site is found in the first intron; an additional site at the 5' end of the fragment fits perfectly the GATA-1 consensus but was not well resolved in these experiments.
The footprints show a total of seven protected sites that contain sequence motifs for binding ofthe factor BGP1 which recognizes runs of seven or more deoxyguanosine residues (16, 17) . Some of these sites are protected only by the erythroid nuclear extract; others are protected by brain nuclear extract as well. Further experiments will be necessary to determine which (if any) of these sites is occupied by BGP1 and which are occupied by other factors. We note that site 8 overlaps a consensus binding sequence for the factor c-myb (18) . A binding site ofpotential interest (site 4) is found at the 5' side of the first intron. The palindromic sequence (AGGTCAgTGACCC), which is protected by brain but not erythroid extracts, closely resembles sequences recognized by several members of the steroid hormone-receptor superfamily (19) (20) (21) (22) Fig. 2 and either including (pGATP1) or excluding (pGATP2) the first intron. These sequences were coupled to the reporter gene for CAT and transfected into primary chicken erythroid cells. Table 1 shows that the 5' region of the GATA-1 gene, extending into the first intron, provides very strong stimulation of CAT expression, three orders of magnitude greater than the pCATBasic vector and four times greater than that seen for the highly active control plasmid pRSV-CAT. For additional comparison, the GATA-1 promoter is 500 times more active than a minimal a-globin promoter (paD3, ref. 5). Deletion of the GATA-1 intron sequences (pGATP2) results in a 4-fold decrease in expression levels.
To test the function of the GATA-1 promoter in a nonerythroid environment, we transfected the test plasmids into primary chicken embryo fibroblasts, together with a GATA-1 expression plasmid (pRSV20-2) or a control GATA-1 antisense plasmid (pRSV20-1). In the absence of GATA-1 expression, the GATA-1 promoter stimulates CAT expression -27 fold compared with a promoterless control ( Table  1) . Without the intron sequences (pGATP2) the basal level is much reduced. Expression of GATA-1 results in a 6-to 8-fold increase in expression for the two constructs. For pGATP1, this represents a total CAT activity =50 fold above background.
DISCUSSION
The chicken GATA-1 gene consists of 6 exons spanning nearly 7 kb of DNA. An earlier analysis of the proteinsequence organization of the mammalian members of the GATA-1 family (10) shows that they contain, in addition to two copies of the finger motif, a different motif (named the R repeat) of which there are three copies. In human and murine GATA-1 two of these copies are N terminal to the finger region and the third is C terminal. Although the finger regions are highly conserved among chicken, mouse, and human, GATA-1, which has recently been cloned, also is divided into 6 exons; beginning at the 3' end of exon 3 and extending to the 3' end of the gene, intron positions are identical to those reported here for chicken (P. Tsai and S. Orkin, personal communication).
The S1 nuclease mapping and primer-extension studies show that the 5' ends of the GATA-1 transcripts are heterogeneous, a characteristic feature of certain genes that lack the TATA motif (23). The results presumably reflect the absence of this transcriptional control element from the corresponding region flanking the major GATA-1 starts.
The DNase I footprinting experiments reveal in the region upstream of the GATA-1 gene numerous sites capable of binding nuclear factors. One such site recognizes a palindromic sequence within intron 1 just downstream of the start sites. This site is a potential binding sequence for members of the steroid hormone-receptor superfamily; these include, among others, the estrogen, thyroid hormone, and retinoic acid receptors and the chicken ovalbumin upstream promoter (COUP)-binding factor (19) (20) (21) (22) . This fact opens the possibility that the intron-binding site plays a significant regulatory role. We note, for example, that thyroid hormone receptors Proc. NatL. Acad. Sci. USA 88 (1991) have been implicated in erythroid-cell differentiation' thus the intron 1 binding site could be a physiologically important target for the product of the viral oncogene v -erb a, which binds to the thyroid hormone response element (TRE) (24) . This site might equally well bind the retinoic acid receptor, known to influence development of the vascular system (25) . Because the binding activity is present in nonerythroid (but not in erythroid) extracts, it may represent a negative regulator of GATA-1 gene activity.
One protected site slightly overlaps, but does not appear to include, the consensus binding sequence for c-myb (18 (1, 3, 5) have shown that GATA-1-binding site clusters can be strong positive cis-acting elements. Our transfection experiments (Table 1) show that the sequences upstream of the GATA-1 coding region can powerfully stimulate CAT reporter gene expression in day-10 embryonic erythroid cells.
Our results indicate that, although GATA-1 is probably important in regulating this promoter, the other factors that bind to the promoter (Figs. 2 and 3 ) also play a role. We do not know whether these factors contribute to the very high activity observed in erythroid cells, but general or fibroblastspecific factors must be responsible for the activities seen in fibroblasts in the absence of GATA-1. Even with GATA-1, expression in fibroblasts never appears to reach the level seen in erythroid cells, due either to the absence of other erythroid-speciflc factors or to the presence of inhibitory components in fibroblasts.
Our experiments indicate that GATA-1 may function in the regulation of its own expression. Autoregulation of regulatory genes is a well-known phenomenon, demonstrated for such genes as MyoD, ftz, and pit-i (27) (28) (29) . Because GATA-1 is expressed in megakaryocytes and mast cells of the mouse, as well as in the erythroid lineage (30) , the events leading to activation of this gene must occur early in hematopoietic development. Other factors, expressed perhaps transiently at these early stages, are probably responsible for activating GATA-1 expression for the first time or for suppressing expression at earlier times.
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